Focus
Our Focus
Pipeline
Dystrophic EB
Netherton Syndrome
TGM1-deficient ARCI
Cystic Fibrosis
Aesthetic Skin Conditions
Chronic Skin Diseases
Patients and Families
Our gene therapy
Our STAR-D platform
Our Targets
Patient Advocacy
Medical Professionals
Team
Investors
Contact
Careers
Contact US
Contact Us
Search for:
We are leading
the development
of corrective and
redosable gene
therapies to offer
hope to patients
facing debilitating
rare diseases.
Learn More
At Krystal, we
are driven by
our mission to
develop innovative
gene therapies to
dramatically improve
people’s lives.
Learn More
Dystrophic Epidermolysis Bullosa
B-VEC
READ MORE
TGM1-deficient ARCI
KB105
READ MORE
Cystic Fibrosis
KB407
READ MORE
Netherton Syndrome
KB104
READ MORE
Additional Dermatological Indications
Our Therapies
READ MORE